Htoon, H. M., Duc, Q. N., Mani, B., Bayer, S., Lam, S. S. W., Nongpiur, M. E., … Matchar, D. (2016). Lifetime Costs and QALYs for POAG patients, early stage versus moderate stage treatment: A Preliminary Discrete Event Simulation cohort study. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 57).

Htoon, Hla Myint, Quang Nguyen Duc, Baskaran Mani, Steffen Bayer, Sean Shao Wei Lam, Monisha Esther Nongpiur, Tin Aung, Eranga Nishanthie Vithana, Ecosse Luc Lamoureux, and David Matchar. “Lifetime Costs and QALYs for POAG patients, early stage versus moderate stage treatment: A Preliminary Discrete Event Simulation cohort study.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 57, 2016.

Htoon HM, Duc QN, Mani B, Bayer S, Lam SSW, Nongpiur ME, et al. Lifetime Costs and QALYs for POAG patients, early stage versus moderate stage treatment: A Preliminary Discrete Event Simulation cohort study. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2016.

Htoon, Hla Myint, et al. “Lifetime Costs and QALYs for POAG patients, early stage versus moderate stage treatment: A Preliminary Discrete Event Simulation cohort study.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 57, no. 12, 2016.

Htoon HM, Duc QN, Mani B, Bayer S, Lam SSW, Nongpiur ME, Aung T, Vithana EN, Lamoureux EL, Matchar D. Lifetime Costs and QALYs for POAG patients, early stage versus moderate stage treatment: A Preliminary Discrete Event Simulation cohort study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2016.